Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population.
<h4>Background</h4>The Seychelles COVID-19 vaccination campaign was initiated using two different vaccines during the first wave of the pandemic in 2021. This observational study estimated vaccine effectiveness against severe outcomes (hospitalisation and/or death) from individuals infec...
Main Authors: | Sylvie Nadine Theresa Pool, Emelyn Helen Shroff, Agnes Chetty, Lara Lewis, Yende-Zuma Nonhlanhla, Salim S Abdool Karim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299747&type=printable |
Similar Items
-
Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2
by: Ahmed Samir Abdelhafiz, et al.
Published: (2022-09-01) -
Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination
by: Rezvan Hosseinzadeh, et al.
Published: (2022-05-01) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
by: Chandima Jeewandara, et al.
Published: (2022-06-01) -
Biochemical and histopathological evaluation of ChAdOx1-S and BBIBP-CorV vaccination in normal and streptozotocin-induced diabetic Wistar rats.
by: Mahsa Teymoorzadeh, et al.
Published: (2023-01-01) -
Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka
by: Jeewandara, C, et al.
Published: (2022)